Advanced search
Publication Cover
Therapeutic Delivery Volume 6, 2015 - Issue 2
Submit an article Journal homepage
67
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Conventional Formulations and Emerging Delivery Systems for the Topical Treatment of Cutaneous Leishmaniasis

Socorro Espuelasa Tropical Health Institute;b Department of Pharmacy & Pharmaceutical Technology, Faculty of Pharmacy, University of Navarra, Pamplona, 31008, SpainCorrespondence[email protected]
Pages 101-103 | Published online: 18 Feb 2015

References

  • WHO . Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniasis, Geneva, 22–26 March 2010.
  • Reithinger R Dujardin JC Louzir H Pirmez C Alexander B Brooker S . Cutaneous Leishmaniasis. Lancet. Infect. Dis.7 (9), 581–596 (2007).
  • Blum J Buffet P Visser L et al. LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travellers. J. Travel. Med.21 (2), 116–129 (2014).
  • Monge-Maillo B Lopez-Velez R . Therapeutic options for Old World Cutaneous Leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis. Drugs73 (17), 1889–1920 (2013).
  • Gonzalez U Pinart M Reveiz L et al. Designing and reporting clinical trials on treatments for Cutaneous Leishmaniasis. Clin. Infect. Dis.51 (4), 409–419 (2010).
  • Gonzalez U Pinart M Rengifo-Pardo M Macaya A Alvar J Tweed JA . Interventions for American Cutaneous and Mucocutaneous Leishmaniasis. Cochrane Database Syst. Rev. (2), CD004834 (2009).
  • Gonzalez U Pinart M Reveiz L Alvar J . Interventions for Old World Cutaneous Leishmaniasis. Cochrane Database Syst. Rev. (4), CD005067 (2008).
  • El-On J Jacobs GP Witztum E Greenblatt CL . Development of topical treatment for Cutaneous Leishmaniasis caused by Leishmania major in experimental animals. Antimicrob. Agents Chemother.26 (5), 745–751 (1984).
  • Kim DH Chung HJ Bleys J Ghohestani RF . Is paromomycin an effective and safe treatment against Cutaneous Leishmaniasis? A meta-analysis of 14 randomized controlled trials. PLoS Negl. Trop. Dis.3 (2), e381 (2009).
  • Ben Salah A Ben Messaoud N Guedri E et al. Topical paromomycin with or without gentamicin for Cutaneous Leishmaniasis. N. Engl. J. Med.368 (6), 524–532 (2013).
  • Sosa N Capitan Z Nieto J et al. Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for Cutaneous Leishmaniasis in Panama. Am. J. Trop. Med. Hyg.89 (3), 557–563 (2013).
  • David CV Craft N . Cutaneous and Mucocutaneous Leishmaniasis. Dermatol. Ther.22 (6), 491–502 (2009).
  • Lane ME Hadgraft J Oliveira G Vieira R Mohammed D Hirata K . Rational formulation design. Int. J. Cosmet. Sci.34 (6), 496–501 (2012).
  • Moreno E Schwartz J Fernandez C et al. Nanoparticles as multifunctional devices for the topical treatment of Cutaneous Leishmaniasis. Expert Opin. Drug Deliv.11 (4), 579–597 (2014).
  • Bavarsad N Fazly Bazzaz BS Khamesipour A Jaafari MR . Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice. Acta Trop.124 (1), 33–41 (2012).
  • Akomeah FK . Topical dermatological drug delivery: quo vadis?Curr. Drug Deliv.7 (4), 283–296 (2010).
  • Dubey V Mishra D Nahar M Jain NK . Vesicles as tools for the modulation of skin permeability. Expert Opin. Drug Deliv.4 (6), 579–593 (2007).
  • Gupta M Agrawal U Vyas SP . Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin. Drug. Deliv.9 (7), 783–804 (2012).
  • Lademann J Richter H Schanzer S et al. Penetration and storage of particles in human skin: perspectives and safety aspects. Eur. J. Pharm. Biopharm.77 (3), 465–468 (2011).
  • Carneiro G Aguiar MG Fernandes AP Ferreira LA . Drug delivery systems for the topical treatment of Cutaneous Leishmaniasis. Expert Opin. Drug. Deliv.9 (9), 1083–1097 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.